You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Acute coronary syndromes

Ticagrelor for preventing atherothrombotic events after myocardial infarction

  • Technology appraisal guidance
  • Reference number: TA420
  • Published:  14 December 2016
  • Guidance
  • Tools and resources
  • Information for the public
  • History

On this page

  1. Expected publication
  2. Final appraisal determination
  3. Draft guidance
  4. Invitation to participate

History

Documents created during the development process.

Expected publication

  • Equality Impact Assessment (Guidance development) (PDF 235 KB)

    Published:
    14 December 2016

Final appraisal determination

  • Final appraisal determination

  • Final appraisal determination document (PDF 281 KB)

    Published:
    04 November 2016
  • Committee papers (PDF 1.09 MB)

    Published:
    04 November 2016
  • Committee papers Committee presentation (PDF 192 KB)

    Published:
    04 November 2016

Draft guidance

  • Draft guidance

  • Appraisal consultation document (PDF 317 KB)

    Published:
    12 August 2016
  • Committee papers (PDF 11.99 MB)

    Published:
    12 August 2016
  • Committee papers committee presentations (PDF 778 KB)

    Published:
    12 August 2016

Invitation to participate

  • Final scope (PDF 110 KB)

    Published:
    11 February 2016
  • Final matrix (PDF 41 KB)

    Published:
    11 February 2016
  • NICE's response to comments on the draft scope and provisional matrix (PDF 132 KB)

    Published:
    11 February 2016
  • Equality Impact Assessment (Guidance development) (PDF 120 KB)

    Published:
    11 February 2016
Back to top